Feature | Coronavirus (COVID-19) | April 01, 2020| Dave Fornell, Editor

Heart Rhythm Society Cancels 2020 Meeting Due to COVID-19

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart Rhythm Society (HRS) has cancelled its large annual electrophysiology meeting that was slated for May 6-9, 2020, in San Diego.

"Our careful evaluation of evolving government advisories, available alternatives, and most importantly the health and well-being of our attendees, the Heart Rhythm Society Board of Trustees regrets to announce that the 2020 Heart Rhythm Scientific Sessions is cancelled," HRS said in a statement sent out this morning.
 
This is the first time in the history of the society that it has ever cancelled an annual meeting. "The decision to cancel was not an easy one, but it was the right choice during these unprecedented events," HRS stated.

Instead of meeting in person, HRS will offer several new digital programs over the next few months on our online learning platform, Heart Rhythm 365. These programs will be available starting May 6, including the #HRS2020 Abstract E-Poster Catalog, Late-Breaking Clinical Trial sessions, and the Young Investigator Awards session.

The Society for Cardiovascular Angiography and Interventions (SCAI) decided to cancel its annual meeting last week. It was also schedule for next month, May 13-16. As virus numbers continue to rise rapidly in both Europe and the U.S., it is widely expected other cardiology and other medical conferences scheduled for May and possibly beyond will follow suit. 

The European Heart Rhythm Association (EHRA), HIMSS, the American College of Cardiology (ACC), Society of Interventional Radiology (SIR), European Society of Radiology (ECR), and numerous other conferences have been cancelling like dominoes since early March as containment efforts tightened and as hospitals began putting travel restrictions on staff in case they were needed for emergency plans if the number of COVID-19 cases rapidly expanded. 

ACC decided the show must go on and hastily created a shorten virtual ACC meeting platform, in which more 38,006 clinicains from 157 countries participated. ACC made the sessions free, and they are accessile on demand for the next 90 days at https://virtual.acc.org/.

ACC and several other medical societies have created COVID-19 resource pages 

In its cancellation letter, the HRS thanked the Scientific Sessions Program Committee, faculty, abstract presenters, exhibitors, sponsors, partners, media, and countless others for their commitment to this year's Heart Rhythm Scientific Sessions.
 

Related COVID-19 News and Meeting Cancellations:

COVID-19 Cancels SCAI Interventional Cardiology Meeting Set for May 2020 

VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with SCAI President Ehtisham Mahmud, M.D.

ACC COVID-19 recommendations for the cardiovascular care team

VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

The Cardiac Implications of Novel Coronavirus

ESC Council on Hypertension Says ACE-I and ARBs Do Not Increase COVID-19 Mortality

Healthcare Societies Issue Urgent Call for Federal Action to Address COVID-19 Medical Equipment Shortages

Healthcare Societies Issue Urgent Call for Federal Action to Address COVID-19 Medical Equipment Shortages

ACC Cancels 2020 Conference Amid Coronavirus Concerns

SIR 2020 Cancelled Due to COVID-19 Outbreak in Seattle

European Heart Rhythm Association Cancelled Due to Coronavirus

VIDEO: Telemedicine in Cardiology and Medical Imaging During COVID-19 — Interview with Regina Druz, M.D.,

COVID-19 Hydroxychloroquine Treatment Brings Prolonged QT Arrhythmia Issues

Related Content

COVID-19 Positive STEMI Patients Have Higher Mortality, First data presented at #TCT2020 on COVID heart attack patients.

Getty Images

News | Coronavirus (COVID-19) | October 14, 2020
October 14, 2020 – The first outcomes data from the...
Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and a very low survival rate.

Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and very low survival rates. Getty Images

Feature | Coronavirus (COVID-19) | October 02, 2020
October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily

An ECMO procedure at Tufts Medical Center in Boston. The FDA cleared the use of ECMO support for COVID-19 patients in April 2020. A new review of patients treated with ECMO showed it had positive outcomes in the most severe COVID-19 patients. Photo by Dave Fornell

News | Coronavirus (COVID-19) | September 29, 2020
September 29, 2020 –  Extracorporeal mem...
hort-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 (SARS-CoV-2) who are risk assessed prior to receiving the drug. That is the finding of research published today in EP Europace, a journal of the European Society of Cardiology (ESC). #COVID19 #SARSCoV2 #hydroxychloroquine
News | Coronavirus (COVID-19) | September 25, 2020
September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients
SARS-CoV-2 infection of cells shown in green, left. This is inhibited by a modified form of cholesterol called 25-hydroxycholesterol (25HC), as seen in the cells in the right image. 25HC activates an enzyme called ACAT, found inside cells in the endoplasmic reticulum. ACAT then depletes accessible cholesterol on the cell’s membrane. It is a normally occurring process that gets kicked into high gear during some viral infections. Image from UC San Diego Health Sciences.

SARS-CoV-2 infection of cells shown in green, left. This is inhibited by a modified form of cholesterol called 25-hydroxycholesterol (25HC), as seen in the cells in the right image. 25HC activates an enzyme called ACAT, found inside cells in the endoplasmic reticulum. ACAT then depletes accessible cholesterol on the cell’s membrane. It is a normally occurring process that gets kicked into high gear during some viral infections. Image from UC San Diego Health Sciences.

News | Coronavirus (COVID-19) | September 24, 2020
September 24, 2020 — Analyzing anonymized patient medical records,...
COVID-19 Therapy Drug Azithromycin May Increase Risk for Cardiac Events

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact o